TY - JOUR
T1 - Enantioseparation by dual-flow countercurrent extraction
T2 - Its application to the enantioseparation of (±)-propranolol
AU - Abe, Yoshihiro
AU - Shoji, Tomoko
AU - Fukui, Shikie
AU - Sasamoto, Maki
AU - Nishizawa, Hideyuki
PY - 1996/8
Y1 - 1996/8
N2 - Enantioseparation of (±)-propranolol has been demonstrated by countercurrent extraction with a two-phase system composed of a chloroform solution of didodecyl L-tartrate (100 mM) and an acetate buffer (50 mM, pH 4.4) containing boric acid (100 mM). The free base of (±)-propranolol (1.6 g) was dissolved in the aqueous phase and extracted five times by means of dual-flow countercurrent extraction. After an additional five extractions for recovery, the crude R-(+)- or S-(-)-form was obtained from the aqueous extracts or organic extracts, respectively. They were isolated as their hydrochloride salts with a purity of 89.8% ee (R-form, 385.7 mg) and 88.3% ee (S-form, 429.5 mg), respectively. They were purified to over 99% ee by recrystallizing twice from 1-propanol.
AB - Enantioseparation of (±)-propranolol has been demonstrated by countercurrent extraction with a two-phase system composed of a chloroform solution of didodecyl L-tartrate (100 mM) and an acetate buffer (50 mM, pH 4.4) containing boric acid (100 mM). The free base of (±)-propranolol (1.6 g) was dissolved in the aqueous phase and extracted five times by means of dual-flow countercurrent extraction. After an additional five extractions for recovery, the crude R-(+)- or S-(-)-form was obtained from the aqueous extracts or organic extracts, respectively. They were isolated as their hydrochloride salts with a purity of 89.8% ee (R-form, 385.7 mg) and 88.3% ee (S-form, 429.5 mg), respectively. They were purified to over 99% ee by recrystallizing twice from 1-propanol.
KW - boric acid
KW - didodecyl L-tartrate
KW - enantioseparation
KW - liquid liquid extraction
KW - propranolol
UR - http://www.scopus.com/inward/record.url?scp=0029739539&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029739539&partnerID=8YFLogxK
U2 - 10.1248/cpb.44.1521
DO - 10.1248/cpb.44.1521
M3 - Article
AN - SCOPUS:0029739539
SN - 0009-2363
VL - 44
SP - 1521
EP - 1524
JO - Chemical and Pharmaceutical Bulletin
JF - Chemical and Pharmaceutical Bulletin
IS - 8
ER -